Fig. 3.

Distribution of single HRQoL domain levels among the 180-day survivors in the two intervention groups. Values are from the responding survivors only (patients (n = 503) and relatives on behalf of patients (n = 73; for these 73 patients, relatives were unable to respond for one patient in the 12 mg group in the usual activities domain and for one patient in the 12 mg group in the anxiety/depression domain)). Patients or relatives answered one of 5 levels (no problems or slight, moderate, severe, or extreme problems) for each of the 5 domains in the EQ-5D-5L survey. The corresponding numeric data are presented in Table S2, ESM 3